The global ventral hernia treatment market garnered a market value of US$ 4.75 billion in 2022 and is expected to accumulate a market value of US$ 9.4 billion by registering a CAGR of 6.4% in the forecast period 2023 to 2033. The growth of the ventral hernia treatment market can be attributed to the increasing incidence of ventral hernias, the rising demand for minimally invasive surgical procedures, the growing geriatric population, and the availability of technologically advanced products and services. The market for ventral hernia treatment registered a CAGR of 3.3% in the historical period 2018 to 2022
A ventral hernia is a condition where a portion of the intestines or other abdominal tissue pushes through a weakened area of the abdominal muscles, causing a bulge or protrusion on the skin's surface.
The treatment of ventral hernias includes surgical procedures like laparoscopic surgery, open surgery, and other minimally invasive techniques. The market for ventral hernia treatment includes medical devices, surgical equipment, pharmaceuticals, and other related products and services used in the diagnosis, treatment, and management of ventral hernias.
| Report Attribute | Details |
|---|---|
| Expected Market Value (2023) | US$ 5.05 Billion |
| Anticipated Forecast Value (2033) | US$ 9.4 Billion |
| Projected Growth Rate (2023 to 2033) | 6.4% CAGR |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
According to market research and competitive intelligence provider Future Market Insights- the market for Ventral hernia treatment reflected a value of 3.3% during the historical period, 2018 to 2022.
The growth was attributed to the increasing prevalence of ventral hernias, the rising demand for minimally invasive surgical procedures, and the availability of advanced hernia repair devices. Moreover, key players have been investing in research and development for innovating novel therapies for ventral hernia treatment. Thus, the market for ventral hernia treatment is expected to register a CAGR of 6.4% in the forecast period 2023 to 2033.
Growing preference for minimally invasive surgical procedures driving market growth
The prevalence of ventral hernias is increasing globally due to several factors such as obesity, aging population, and sedentary lifestyle. This has led to a rise in demand for hernia repair surgeries and related products and services. The development of advanced hernia repair devices such as mesh implants, surgical staplers, and robotic-assisted surgical systems has improved the efficiency and safety of hernia repair surgeries, leading to increased adoption of these devices.
Minimally invasive surgical procedures, such as laparoscopic surgery, offer several advantages over traditional open surgeries, including reduced pain, faster recovery, and shorter hospital stays. This has led to a growing preference for minimally invasive procedures among patients and healthcare providers.
Awareness and education campaigns by healthcare organizations and governments have helped to increase public awareness about ventral hernias and their treatment options, leading to increased demand for hernia repair surgeries and related products and services. The increasing healthcare spending globally, particularly in emerging markets, has led to increased access to healthcare services, including hernia repair surgeries and related products and services.
Availability of treatments shaping landscape for ventral hernias treatment market
Principal Consultant
High cost of treatment along with reimbursement issues derailing market growth for ventral hernia treatment market
The cost of hernia repair surgeries and related products and services can be high, particularly for uninsured or underinsured patients, which can limit access to care. In some countries, reimbursement policies for hernia repair surgeries may be inadequate, which can limit access to care and affect the demand for hernia repair devices and related products and services.
Despite efforts to increase awareness about hernias and their treatment options, many people may still be unaware of the condition, which can delay diagnosis and treatment. Like any surgical procedure, hernia repair surgeries carry risks of complications such as infection, bleeding, and nerve damage.
The ventral hernia treatment market is highly competitive, with several key players operating in the industry, which can make it difficult for new entrants to establish themselves and compete with established players. The ventral hernia treatment market is subject to various regulations and standards, which can affect the development and commercialization of hernia repair devices and related products and services.
Growing preference for minimally invasive surgeries driving market growth in North America
The North American ventral hernia treatment market is a significant market segment within the global hernia treatment market. North America is one of the largest markets for hernia treatment globally, and it includes the United States and Canada.
The increasing prevalence of obesity and an aging population in North America has contributed to the rising incidence of ventral hernias in the region. This, in turn, has led to an increase in demand for hernia repair surgeries and related products and services.
The North America ventral hernia treatment market is highly competitive, with several key players operating in the industry. These companies are investing heavily in research and development to develop advanced hernia repair devices and surgical techniques.
The market is also witnessing a growing preference for minimally invasive surgical procedures, such as laparoscopic surgery, over traditional open surgeries. This trend is driven by the benefits of minimally invasive procedures, including reduced pain, faster recovery, and shorter hospital stays.
Overall, the North America ventral hernia treatment market is expected to continue to grow in the coming years, driven by increasing awareness and education about hernias, advances in hernia repair devices and surgical techniques, and the rising incidence of ventral hernias in the region. Thus, North America is expected to possess a 46% market share for ventral hernia treatment market.
Rising demand for outpatient procedures bolstering growth of ventral hernia treatment market in Europe
The incidence of ventral hernias is increasing in Europe due to factors such as an aging population, sedentary lifestyles, and obesity. This has led to an increase in demand for hernia repair surgeries and related products and services.
The development of new and innovative hernia repair devices and surgical techniques is driving growth in the Europe ventral hernia treatment market. For example, the use of minimally invasive laparoscopic surgery techniques is increasing in popularity, as it is associated with faster recovery times and reduced pain compared to traditional open surgery.
There is a growing trend towards outpatient hernia repair surgeries in Europe. Outpatient surgeries are less expensive and more convenient for patients, which is driving growth in the ventral hernia treatment market. Many countries in Europe have favorable reimbursement policies for hernia repair surgeries, which is helping to drive growth in the ventral hernia treatment market.
There is growing awareness and education about hernias and their treatment options among healthcare providers and the general public in Europe, which is driving demand for hernia repair products and services. Thus, Europe is expected to possess a 38% market share for ventral hernia treatment market.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Availability of specialized medical staff maximizing the use of hospitals for ventral hernia treatment
Hospitals have a team of specialized medical staff, including surgeons, anesthesiologists, and nurses, who are trained and experienced in treating ventral hernias. These healthcare professionals have the necessary skills and knowledge to provide effective hernia treatment and manage any complications that may arise during or after the procedure.
Hospitals are equipped with advanced technology and equipment that are necessary for performing hernia surgeries safely and effectively. This includes surgical instruments, imaging technology, and monitoring devices that help ensure the patient's safety and well-being during the procedure.
After hernia surgery, patients require ongoing care and monitoring to ensure proper healing and prevent complications. Hospitals provide a range of post-operative care services, including pain management, wound care, and physical therapy, that can help patients recover more quickly and with fewer complications.
In rare cases, hernia surgery can lead to complications that require emergency medical attention. Hospitals are equipped to handle emergencies and have the necessary resources to provide life-saving care if needed. Thus, hospitals are expected to possess a 48% market share for ventral hernia treatment market.
Key players in the ventral hernia treatment market are Medtronic, Becton Dickinson & Company, Braun Melsungen AG, Cook Medical Inc., Cooper Companies Inc., Baxter International, Inc., Integra LifeSciences, W.L. Gore & Associates, AbbVie, Johnson & Johnson Services, Inc.
| Report Attribute | Details |
|---|---|
| Market Value in 2023 | US$ 5.05 Billion |
| Market Value in 2033 | US$ 9.4 Billion |
| Growth Rate | CAGR of 6.4% from 2023 to 2033 |
| Base Year for Estimation | 2022 |
| Historical Data | 2018 to 2022 |
| Forecast Period | 2023 to 2033 |
| Quantitative Units | Revenue in USD Billion and CAGR from 2023 to 2033 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segments Covered |
|
| Regions Covered |
|
| Key Countries Profiled |
|
| Key Companies Profiled |
|
| Customization | Available Upon Request |
The industry is valued at US$ 5.05 billion in 2023.
Ethicon, Bard, and Aesculap are key industry players.
The key consumer of the ventral hernia treatment market is the healthcare industry.
The industry is estimated to reach US$ 9.4 billion by 2033.
The ventral hernia treatment market CAGR for 2033 is 6.4%.
1. Executive Summary | Ventral Hernia Treatment Market
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Ventral Hernia Treatment Market Analysis 2018-2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) Analysis, 2018-2022
4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Ventral Hernia Treatment Market Analysis 2018-2022 and Forecast 2023 to 2033, By Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Type, 2018-2022
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Type, 2023 to 2033
5.3.1. Epigastric (stomach area) hernia
5.3.2. Umbilical (belly button) hernia
5.3.3. Incisional hernia
5.4. Y-o-Y Growth Trend Analysis By Type, 2018-2022
5.5. Absolute $ Opportunity Analysis By Type, 2023 to 2033
6. Global Ventral Hernia Treatment Market Analysis 2018-2022 and Forecast 2023 to 2033, By Diagnosis
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By Diagnosis, 2018-2022
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Diagnosis, 2023 to 2033
6.3.1. Ultrasound
6.3.2. CT scan
6.3.3. MRI
6.4. Y-o-Y Growth Trend Analysis By Diagnosis, 2018-2022
6.5. Absolute $ Opportunity Analysis By Diagnosis, 2023 to 2033
7. Global Ventral Hernia Treatment Market Analysis 2018-2022 and Forecast 2023 to 2033, By Surgery Type
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) Analysis By Surgery Type , 2018-2022
7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Surgery Type , 2023 to 2033
7.3.1. Open hernia surgery
7.3.2. Laparoscopic surgery
7.3.3. Robotic hernia surgery
7.4. Y-o-Y Growth Trend Analysis By Surgery Type , 2018-2022
7.5. Absolute $ Opportunity Analysis By Surgery Type , 2023 to 2033
8. Global Ventral Hernia Treatment Market Analysis 2018-2022 and Forecast 2023 to 2033, By End-use
8.1. Introduction / Key Findings
8.2. Historical Market Size Value (US$ Million) Analysis By End-use, 2018-2022
8.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End-use, 2023 to 2033
8.3.1. Hospitals
8.3.2. Ambulatory Surgical Centres
8.3.3. Clinics
8.4. Y-o-Y Growth Trend Analysis By End-use, 2018-2022
8.5. Absolute $ Opportunity Analysis By End-use, 2023 to 2033
9. Global Ventral Hernia Treatment Market Analysis 2018-2022 and Forecast 2023 to 2033, By Region
9.1. Introduction
9.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018-2022
9.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033
9.3.1. North America
9.3.2. Latin America
9.3.3. Europe
9.3.4. South Asia
9.3.5. East Asia
9.3.6. Oceania
9.3.7. MEA
9.4. Market Attractiveness Analysis By Region
10. North America Ventral Hernia Treatment Market Analysis 2018-2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. USA
10.2.1.2. Canada
10.2.2. By Type
10.2.3. By Diagnosis
10.2.4. By Surgery Type
10.2.5. By End-use
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Type
10.3.3. By Diagnosis
10.3.4. By Surgery Type
10.3.5. By End-use
10.4. Key Takeaways
11. Latin America Ventral Hernia Treatment Market Analysis 2018-2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. Brazil
11.2.1.2. Mexico
11.2.1.3. Rest of Latin America
11.2.2. By Type
11.2.3. By Diagnosis
11.2.4. By Surgery Type
11.2.5. By End-use
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Type
11.3.3. By Diagnosis
11.3.4. By Surgery Type
11.3.5. By End-use
11.4. Key Takeaways
12. Europe Ventral Hernia Treatment Market Analysis 2018-2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. Germany
12.2.1.2. U.K.
12.2.1.3. France
12.2.1.4. Spain
12.2.1.5. Italy
12.2.1.6. Rest of Europe
12.2.2. By Type
12.2.3. By Diagnosis
12.2.4. By Surgery Type
12.2.5. By End-use
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Type
12.3.3. By Diagnosis
12.3.4. By Surgery Type
12.3.5. By End-use
12.4. Key Takeaways
13. South Asia Ventral Hernia Treatment Market Analysis 2018-2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. India
13.2.1.2. Malaysia
13.2.1.3. Singapore
13.2.1.4. Thailand
13.2.1.5. Rest of South Asia
13.2.2. By Type
13.2.3. By Diagnosis
13.2.4. By Surgery Type
13.2.5. By End-use
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Type
13.3.3. By Diagnosis
13.3.4. By Surgery Type
13.3.5. By End-use
13.4. Key Takeaways
14. East Asia Ventral Hernia Treatment Market Analysis 2018-2022 and Forecast 2023 to 2033, By Country
14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022
14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
14.2.1. By Country
14.2.1.1. China
14.2.1.2. Japan
14.2.1.3. South Korea
14.2.2. By Type
14.2.3. By Diagnosis
14.2.4. By Surgery Type
14.2.5. By End-use
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Type
14.3.3. By Diagnosis
14.3.4. By Surgery Type
14.3.5. By End-use
14.4. Key Takeaways
15. Oceania Ventral Hernia Treatment Market Analysis 2018-2022 and Forecast 2023 to 2033, By Country
15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022
15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
15.2.1. By Country
15.2.1.1. Australia
15.2.1.2. New Zealand
15.2.2. By Type
15.2.3. By Diagnosis
15.2.4. By Surgery Type
15.2.5. By End-use
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Type
15.3.3. By Diagnosis
15.3.4. By Surgery Type
15.3.5. By End-use
15.4. Key Takeaways
16. MEA Ventral Hernia Treatment Market Analysis 2018-2022 and Forecast 2023 to 2033, By Country
16.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022
16.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
16.2.1. By Country
16.2.1.1. GCC Countries
16.2.1.2. South Africa
16.2.1.3. Israel
16.2.1.4. Rest of MEA
16.2.2. By Type
16.2.3. By Diagnosis
16.2.4. By Surgery Type
16.2.5. By End-use
16.3. Market Attractiveness Analysis
16.3.1. By Country
16.3.2. By Type
16.3.3. By Diagnosis
16.3.4. By Surgery Type
16.3.5. By End-use
16.4. Key Takeaways
17. Key Countries Ventral Hernia Treatment Market Analysis
17.1. USA
17.1.1. Pricing Analysis
17.1.2. Market Share Analysis, 2022
17.1.2.1. By Type
17.1.2.2. By Diagnosis
17.1.2.3. By Surgery Type
17.1.2.4. By End-use
17.2. Canada
17.2.1. Pricing Analysis
17.2.2. Market Share Analysis, 2022
17.2.2.1. By Type
17.2.2.2. By Diagnosis
17.2.2.3. By Surgery Type
17.2.2.4. By End-use
17.3. Brazil
17.3.1. Pricing Analysis
17.3.2. Market Share Analysis, 2022
17.3.2.1. By Type
17.3.2.2. By Diagnosis
17.3.2.3. By Surgery Type
17.3.2.4. By End-use
17.4. Mexico
17.4.1. Pricing Analysis
17.4.2. Market Share Analysis, 2022
17.4.2.1. By Type
17.4.2.2. By Diagnosis
17.4.2.3. By Surgery Type
17.4.2.4. By End-use
17.5. Germany
17.5.1. Pricing Analysis
17.5.2. Market Share Analysis, 2022
17.5.2.1. By Type
17.5.2.2. By Diagnosis
17.5.2.3. By Surgery Type
17.5.2.4. By End-use
17.6. United kingdom
17.6.1. Pricing Analysis
17.6.2. Market Share Analysis, 2022
17.6.2.1. By Type
17.6.2.2. By Diagnosis
17.6.2.3. By Surgery Type
17.6.2.4. By End-use
17.7. France
17.7.1. Pricing Analysis
17.7.2. Market Share Analysis, 2022
17.7.2.1. By Type
17.7.2.2. By Diagnosis
17.7.2.3. By Surgery Type
17.7.2.4. By End-use
17.8. Spain
17.8.1. Pricing Analysis
17.8.2. Market Share Analysis, 2022
17.8.2.1. By Type
17.8.2.2. By Diagnosis
17.8.2.3. By Surgery Type
17.8.2.4. By End-use
17.9. Italy
17.9.1. Pricing Analysis
17.9.2. Market Share Analysis, 2022
17.9.2.1. By Type
17.9.2.2. By Diagnosis
17.9.2.3. By Surgery Type
17.9.2.4. By End-use
17.10. India
17.10.1. Pricing Analysis
17.10.2. Market Share Analysis, 2022
17.10.2.1. By Type
17.10.2.2. By Diagnosis
17.10.2.3. By Surgery Type
17.10.2.4. By End-use
17.11. Malaysia
17.11.1. Pricing Analysis
17.11.2. Market Share Analysis, 2022
17.11.2.1. By Type
17.11.2.2. By Diagnosis
17.11.2.3. By Surgery Type
17.11.2.4. By End-use
17.12. Singapore
17.12.1. Pricing Analysis
17.12.2. Market Share Analysis, 2022
17.12.2.1. By Type
17.12.2.2. By Diagnosis
17.12.2.3. By Surgery Type
17.12.2.4. By End-use
17.13. Thailand
17.13.1. Pricing Analysis
17.13.2. Market Share Analysis, 2022
17.13.2.1. By Type
17.13.2.2. By Diagnosis
17.13.2.3. By Surgery Type
17.13.2.4. By End-use
17.14. China
17.14.1. Pricing Analysis
17.14.2. Market Share Analysis, 2022
17.14.2.1. By Type
17.14.2.2. By Diagnosis
17.14.2.3. By Surgery Type
17.14.2.4. By End-use
17.15. Japan
17.15.1. Pricing Analysis
17.15.2. Market Share Analysis, 2022
17.15.2.1. By Type
17.15.2.2. By Diagnosis
17.15.2.3. By Surgery Type
17.15.2.4. By End-use
17.16. South Korea
17.16.1. Pricing Analysis
17.16.2. Market Share Analysis, 2022
17.16.2.1. By Type
17.16.2.2. By Diagnosis
17.16.2.3. By Surgery Type
17.16.2.4. By End-use
17.17. Australia
17.17.1. Pricing Analysis
17.17.2. Market Share Analysis, 2022
17.17.2.1. By Type
17.17.2.2. By Diagnosis
17.17.2.3. By Surgery Type
17.17.2.4. By End-use
17.18. New Zealand
17.18.1. Pricing Analysis
17.18.2. Market Share Analysis, 2022
17.18.2.1. By Type
17.18.2.2. By Diagnosis
17.18.2.3. By Surgery Type
17.18.2.4. By End-use
17.19. GCC Countries
17.19.1. Pricing Analysis
17.19.2. Market Share Analysis, 2022
17.19.2.1. By Type
17.19.2.2. By Diagnosis
17.19.2.3. By Surgery Type
17.19.2.4. By End-use
17.20. South Africa
17.20.1. Pricing Analysis
17.20.2. Market Share Analysis, 2022
17.20.2.1. By Type
17.20.2.2. By Diagnosis
17.20.2.3. By Surgery Type
17.20.2.4. By End-use
17.21. Israel
17.21.1. Pricing Analysis
17.21.2. Market Share Analysis, 2022
17.21.2.1. By Type
17.21.2.2. By Diagnosis
17.21.2.3. By Surgery Type
17.21.2.4. By End-use
18. Market Structure Analysis
18.1. Competition Dashboard
18.2. Competition Benchmarking
18.3. Market Share Analysis of Top Players
18.3.1. By Regional
18.3.2. By Type
18.3.3. By Diagnosis
18.3.4. By Surgery Type
18.3.5. By End-use
19. Competition Analysis
19.1. Competition Deep Dive
19.1.1. Medtronic
19.1.1.1. Overview
19.1.1.2. Product Portfolio
19.1.1.3. Profitability by Market Segments
19.1.1.4. Sales Footprint
19.1.1.5. Strategy Overview
19.1.1.5.1. Marketing Strategy
19.1.2. Becton Dickinson & Company
19.1.2.1. Overview
19.1.2.2. Product Portfolio
19.1.2.3. Profitability by Market Segments
19.1.2.4. Sales Footprint
19.1.2.5. Strategy Overview
19.1.2.5.1. Marketing Strategy
19.1.3. B. Braun Melsungen AG
19.1.3.1. Overview
19.1.3.2. Product Portfolio
19.1.3.3. Profitability by Market Segments
19.1.3.4. Sales Footprint
19.1.3.5. Strategy Overview
19.1.3.5.1. Marketing Strategy
19.1.4. Cook Medical Inc.
19.1.4.1. Overview
19.1.4.2. Product Portfolio
19.1.4.3. Profitability by Market Segments
19.1.4.4. Sales Footprint
19.1.4.5. Strategy Overview
19.1.4.5.1. Marketing Strategy
19.1.5. Cooper Companies Inc.
19.1.5.1. Overview
19.1.5.2. Product Portfolio
19.1.5.3. Profitability by Market Segments
19.1.5.4. Sales Footprint
19.1.5.5. Strategy Overview
19.1.5.5.1. Marketing Strategy
19.1.6. Baxter International, Inc.
19.1.6.1. Overview
19.1.6.2. Product Portfolio
19.1.6.3. Profitability by Market Segments
19.1.6.4. Sales Footprint
19.1.6.5. Strategy Overview
19.1.6.5.1. Marketing Strategy
19.1.7. Integra LifeSciences
19.1.7.1. Overview
19.1.7.2. Product Portfolio
19.1.7.3. Profitability by Market Segments
19.1.7.4. Sales Footprint
19.1.7.5. Strategy Overview
19.1.7.5.1. Marketing Strategy
19.1.8. W.L. Gore & Associates
19.1.8.1. Overview
19.1.8.2. Product Portfolio
19.1.8.3. Profitability by Market Segments
19.1.8.4. Sales Footprint
19.1.8.5. Strategy Overview
19.1.8.5.1. Marketing Strategy
19.1.9. AbbVie
19.1.9.1. Overview
19.1.9.2. Product Portfolio
19.1.9.3. Profitability by Market Segments
19.1.9.4. Sales Footprint
19.1.9.5. Strategy Overview
19.1.9.5.1. Marketing Strategy
19.1.10. Johnson & Johnson Services, Inc.
19.1.10.1. Overview
19.1.10.2. Product Portfolio
19.1.10.3. Profitability by Market Segments
19.1.10.4. Sales Footprint
19.1.10.5. Strategy Overview
19.1.10.5.1. Marketing Strategy
20. Assumptions & Acronyms Used
21. Research Methodology
Explore Healthcare Insights
View Reports
Ventral Hernia Treatment Market
